APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Aging Products and Therapies

Anti-Aging Products and Therapies is the product which delay, stop or retard the aging process.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Anti-Aging Products and Therapies is the product which delay, stop or retard the aging process.

In our report we counted medical technique product which delay aging process. Unit means the amount of product use in single time.

Selected research

Market Analysis & Forecast

Global Anti-Aging Products and Therapies Market Analysis and Forecast 2026-2032

2 January 2026198 pages

Choose your research edition.

Industry ResearchAnti-Aging Products and Therapies Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Aging Products and Therapies Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Anti-Aging Products and Therapies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Aging Products and Therapies Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Aging Products and Therapies Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Anti-Aging Products and Therapies is the product which delay, stop or retard the aging process.

In our report we counted medical technique product which delay aging process. Unit means the amount of product use in single time.

The major players in global Anti-Aging Products and Therapies market include Merck, Gaoxin, etc. The top 2 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy over 50% of the global market. Human Growth Hormone, Botulinus Toxin and Hyaluronic Acid are main types, with a share about 99%. Beauty Parlor is the main application, which holds a share about 60%.

Read the full market overview

Report Includes

This report presents an overview of global market for Anti-Aging Products and Therapies, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti-Aging Products and Therapies, also provides the revenue of main regions and countries. Of the upcoming market potential for Anti-Aging Products and Therapies, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-Aging Products and Therapies revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-Aging Products and Therapies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Anti-Aging Products and Therapies revenue, projected growth trends, production technology, application and end-user industry.

Anti-Aging Products and Therapies Segment by Company

Allergan

Ipsen

Lanzhou Institute

Corneal(Allergan)

Galdermal

LG Life Science

Bohus BioTech

IMEIK

Merck

Gaoxin

Anti-Aging Products and Therapies Segment by Type

Human Growth Hormone

Stem Cell

Placenta

Botulinus Toxin

Hyaluronic Acid

Anti-Aging Products and Therapies Segment by Application

Hospital

Beauty Parlor

Anti-Aging Products and Therapies Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Aging Products and Therapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Aging Products and Therapies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Aging Products and Therapies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Anti-Aging Products and Therapies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Anti-Aging Products and Therapies company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Aging Products and Therapies revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-Aging Products and Therapies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Human Growth Hormone Major Player Table 3. Stem Cell Major Player Table 4. Placenta Major Player Table 5. Botulinus Toxin Major Player Table 6. Hyaluronic Acid Major Player Table 7. Global Anti-Aging Products and Therapies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Player Table 9. Beauty Parlor Major Player Table 10. Anti-Aging Products and Therapies Industry Trends Table 11. Anti-Aging Products and Therapies Industry Drivers Table 12. Anti-Aging Products and Therapies Industry Opportunities and Challenges Table 13. Anti-Aging Products and Therapies Industry Restraints Table 14. Global Anti-Aging Products and Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Anti-Aging Products and Therapies Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Anti-Aging Products and Therapies Market Share by Region (2021-2026) Table 17. Global Anti-Aging Products and Therapies Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Anti-Aging Products and Therapies Market Share by Region (2027-2032) Table 19. Global Anti-Aging Products and Therapies Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Anti-Aging Products and Therapies Revenue Market Share by Players (2021-2026) Table 21. Global Anti-Aging Products and Therapies Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Anti-Aging Products and Therapies Key Players Headquarters & Area Served Table 23. Global Anti-Aging Products and Therapies Players, Product Type & Application Table 24. Global Anti-Aging Products and Therapies Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Anti-Aging Products and Therapies by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Anti-Aging Products and Therapies Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Anti-Aging Products and Therapies Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Anti-Aging Products and Therapies Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Anti-Aging Products and Therapies Revenue Market Share by Type (2021-2026) Table 31. Global Anti-Aging Products and Therapies Revenue Market Share by Type (2027-2032) Table 32. Global Anti-Aging Products and Therapies Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Anti-Aging Products and Therapies Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Anti-Aging Products and Therapies Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Anti-Aging Products and Therapies Revenue Market Share by Application (2021-2026) Table 36. Global Anti-Aging Products and Therapies Revenue Market Share by Application (2027-2032) Table 37. Allergan Company Information Table 38. Allergan Business Overview Table 39. Allergan Anti-Aging Products and Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Allergan Anti-Aging Products and Therapies Product Portfolio Table 41. Allergan Recent Development Table 42. Ipsen Company Information Table 43. Ipsen Business Overview Table 44. Ipsen Anti-Aging Products and Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Ipsen Anti-Aging Products and Therapies Product Portfolio Table 46. Ipsen Recent Development Table 47. Lanzhou Institute Company Information Table 48. Lanzhou Institute Business Overview Table 49. Lanzhou Institute Anti-Aging Products and Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Lanzhou Institute Anti-Aging Products and Therapies Product Portfolio Table 51. Lanzhou Institute Recent Development Table 52. Corneal(Allergan) Company Information Table 53. Corneal(Allergan) Business Overview Table 54. Corneal(Allergan) Anti-Aging Products and Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Corneal(Allergan) Anti-Aging Products and Therapies Product Portfolio Table 56. Corneal(Allergan) Recent Development Table 57. Galdermal Company Information Table 58. Galdermal Business Overview Table 59. Galdermal Anti-Aging Products and Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Galdermal Anti-Aging Products and Therapies Product Portfolio Table 61. Galdermal Recent Development Table 62. LG Life Science Company Information Table 63. LG Life Science Business Overview Table 64. LG Life Science Anti-Aging Products and Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. LG Life Science Anti-Aging Products and Therapies Product Portfolio Table 66. LG Life Science Recent Development Table 67. Bohus BioTech Company Information Table 68. Bohus BioTech Business Overview Table 69. Bohus BioTech Anti-Aging Products and Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Bohus BioTech Anti-Aging Products and Therapies Product Portfolio Table 71. Bohus BioTech Recent Development Table 72. IMEIK Company Information Table 73. IMEIK Business Overview Table 74. IMEIK Anti-Aging Products and Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. IMEIK Anti-Aging Products and Therapies Product Portfolio Table 76. IMEIK Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Anti-Aging Products and Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Merck Anti-Aging Products and Therapies Product Portfolio Table 81. Merck Recent Development Table 82. Gaoxin Company Information Table 83. Gaoxin Business Overview Table 84. Gaoxin Anti-Aging Products and Therapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Gaoxin Anti-Aging Products and Therapies Product Portfolio Table 86. Gaoxin Recent Development Table 87. North America Anti-Aging Products and Therapies Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Anti-Aging Products and Therapies Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Anti-Aging Products and Therapies Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Anti-Aging Products and Therapies Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Anti-Aging Products and Therapies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Anti-Aging Products and Therapies Revenue by Country (2021-2026) & (US$ Million) Table 93. North America Anti-Aging Products and Therapies Revenue by Country (US$ Million) & (2027-2032) Table 94. Europe Anti-Aging Products and Therapies Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Anti-Aging Products and Therapies Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Anti-Aging Products and Therapies Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Anti-Aging Products and Therapies Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Anti-Aging Products and Therapies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Anti-Aging Products and Therapies Revenue by Country (2021-2026) & (US$ Million) Table 100. Europe Anti-Aging Products and Therapies Revenue by Country (US$ Million) & (2027-2032) Table 101. China Anti-Aging Products and Therapies Revenue by Type (2021-2026) & (US$ Million) Table 102. China Anti-Aging Products and Therapies Revenue by Type (2027-2032) & (US$ Million) Table 103. China Anti-Aging Products and Therapies Revenue by Application (2021-2026) & (US$ Million) Table 104. China Anti-Aging Products and Therapies Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia Anti-Aging Products and Therapies Revenue by Type (2021-2026) & (US$ Million) Table 106. Asia Anti-Aging Products and Therapies Revenue by Type (2027-2032) & (US$ Million) Table 107. Asia Anti-Aging Products and Therapies Revenue by Application (2021-2026) & (US$ Million) Table 108. Asia Anti-Aging Products and Therapies Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Anti-Aging Products and Therapies Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia Anti-Aging Products and Therapies Revenue by Region (US$ Million) & (2021-2026) Table 111. Asia Anti-Aging Products and Therapies Revenue by Region (US$ Million) & (2027-2032) Table 112. SAMEA Anti-Aging Products and Therapies Revenue by Type (2021-2026) & (US$ Million) Table 113. SAMEA Anti-Aging Products and Therapies Revenue by Type (2027-2032) & (US$ Million) Table 114. SAMEA Anti-Aging Products and Therapies Revenue by Application (2021-2026) & (US$ Million) Table 115. SAMEA Anti-Aging Products and Therapies Revenue by Application (2027-2032) & (US$ Million) Table 116. SAMEA Anti-Aging Products and Therapies Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. SAMEA Anti-Aging Products and Therapies Revenue by Country (2021-2026) & (US$ Million) Table 118. SAMEA Anti-Aging Products and Therapies Revenue by Country (US$ Million) & (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Anti-Aging Products and Therapies Image Figure 2. Global Anti-Aging Products and Therapies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Aging Products and Therapies Market Size Share 2021 VS 2025 VS 2032 Figure 4. Human Growth Hormone Image Figure 5. Stem Cell Image Figure 6. Placenta Image Figure 7. Botulinus Toxin Image Figure 8. Hyaluronic Acid Image Figure 9. Global Anti-Aging Products and Therapies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Anti-Aging Products and Therapies Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Beauty Parlor Image Figure 13. Global Anti-Aging Products and Therapies Market Size (US$ Million) & (2021-2032) Figure 14. Global Anti-Aging Products and Therapies Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Anti-Aging Products and Therapies Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Anti-Aging Products and Therapies Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Anti-Aging Products and Therapies Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Anti-Aging Products and Therapies Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Anti-Aging Products and Therapies Revenue Market Share by Type (2021-2032) Figure 21. Global Anti-Aging Products and Therapies Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Anti-Aging Products and Therapies Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Anti-Aging Products and Therapies Revenue Market Share by Application (2021-2032) Figure 24. North America Anti-Aging Products and Therapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Anti-Aging Products and Therapies Revenue Share by Type (2021-2032) Figure 26. North America Anti-Aging Products and Therapies Revenue Share by Application (2021-2032) Figure 27. North America Anti-Aging Products and Therapies Revenue Share by Country (2021-2032) Figure 28. United States Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Anti-Aging Products and Therapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Anti-Aging Products and Therapies Revenue Share by Type (2021-2032) Figure 33. Europe Anti-Aging Products and Therapies Revenue Share by Application (2021-2032) Figure 34. Europe Anti-Aging Products and Therapies Revenue Share by Country (2021-2032) Figure 35. Germany Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Anti-Aging Products and Therapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Anti-Aging Products and Therapies Revenue Share by Type (2021-2032) Figure 45. China Anti-Aging Products and Therapies Revenue Share by Application (2021-2032) Figure 46. Asia Anti-Aging Products and Therapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Anti-Aging Products and Therapies Revenue Share by Type (2021-2032) Figure 48. Asia Anti-Aging Products and Therapies Revenue Share by Application (2021-2032) Figure 49. Asia Anti-Aging Products and Therapies Revenue Share by Region (2021-2032) Figure 50. Japan Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Anti-Aging Products and Therapies Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Anti-Aging Products and Therapies Revenue Share by Type (2021-2032) Figure 58. SAMEA Anti-Aging Products and Therapies Revenue Share by Application (2021-2032) Figure 59. SAMEA Anti-Aging Products and Therapies Revenue Share by Country (2021-2032) Figure 60. Brazil Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Anti-Aging Products and Therapies Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Human Growth Hormone
  • Stem Cell
  • Placenta
  • Botulinus Toxin
  • Hyaluronic Acid
Applications
  • Hospital
  • Beauty Parlor
Companies covered
  • Allergan
  • Ipsen
  • Lanzhou Institute
  • Corneal(Allergan)
  • Galdermal
  • LG Life Science
  • Bohus BioTech
  • IMEIK
  • Merck
  • Gaoxin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti-Aging Products and Therapies Market by Type
  3. 1.2.1 Global Anti-Aging Products and Therapies Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Human Growth Hormone
  5. 1.2.3 Stem Cell
  6. 1.2.4 Placenta
  7. 1.2.5 Botulinus Toxin
  8. 1.2.6 Hyaluronic Acid
  9. 1.3 Anti-Aging Products and Therapies Market by Application
  10. 1.3.1 Global Anti-Aging Products and Therapies Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Beauty Parlor
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Anti-Aging Products and Therapies Market Dynamics
  1. 2.1 Anti-Aging Products and Therapies Industry Trends
  2. 2.2 Anti-Aging Products and Therapies Industry Drivers
  3. 2.3 Anti-Aging Products and Therapies Industry Opportunities and Challenges
  4. 2.4 Anti-Aging Products and Therapies Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Anti-Aging Products and Therapies Market Perspective (2021-2032)
  2. 3.2 Global Anti-Aging Products and Therapies Growth Trends by Region
  3. 3.2.1 Global Anti-Aging Products and Therapies Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti-Aging Products and Therapies Market Size by Region (2021-2026)
  5. 3.2.3 Global Anti-Aging Products and Therapies Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Anti-Aging Products and Therapies Revenue by Players
  2. 4.1.1 Global Anti-Aging Products and Therapies Revenue by Players (2021-2026)
  3. 4.1.2 Global Anti-Aging Products and Therapies Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Anti-Aging Products and Therapies Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti-Aging Products and Therapies Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Anti-Aging Products and Therapies Key Players Headquarters & Area Served
  7. 4.4 Global Anti-Aging Products and Therapies Players, Product Type & Application
  8. 4.5 Global Anti-Aging Products and Therapies Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Anti-Aging Products and Therapies Market CR5 and HHI
  11. 4.6.3 2025 Anti-Aging Products and Therapies Tier 1, Tier 2, and Tier 3
5 Anti-Aging Products and Therapies Market Size by Type
  1. 5.1 Global Anti-Aging Products and Therapies Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Anti-Aging Products and Therapies Revenue by Type (2021-2032)
  3. 5.3 Global Anti-Aging Products and Therapies Revenue Market Share by Type (2021-2032)
6 Anti-Aging Products and Therapies Market Size by Application
  1. 6.1 Global Anti-Aging Products and Therapies Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Anti-Aging Products and Therapies Revenue by Application (2021-2032)
  3. 6.3 Global Anti-Aging Products and Therapies Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Allergan
  2. 7.1.1 Allergan Company Information
  3. 7.1.2 Allergan Business Overview
  4. 7.1.3 Allergan Anti-Aging Products and Therapies Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Allergan Anti-Aging Products and Therapies Product Portfolio
  6. 7.1.5 Allergan Recent Developments
  7. 7.2 Ipsen
  8. 7.2.1 Ipsen Company Information
  9. 7.2.2 Ipsen Business Overview
  10. 7.2.3 Ipsen Anti-Aging Products and Therapies Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Ipsen Anti-Aging Products and Therapies Product Portfolio
  12. 7.2.5 Ipsen Recent Developments
  13. 7.3 Lanzhou Institute
  14. 7.3.1 Lanzhou Institute Company Information
  15. 7.3.2 Lanzhou Institute Business Overview
  16. 7.3.3 Lanzhou Institute Anti-Aging Products and Therapies Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Lanzhou Institute Anti-Aging Products and Therapies Product Portfolio
  18. 7.3.5 Lanzhou Institute Recent Developments
  19. 7.4 Corneal(Allergan)
  20. 7.4.1 Corneal(Allergan) Company Information
  21. 7.4.2 Corneal(Allergan) Business Overview
  22. 7.4.3 Corneal(Allergan) Anti-Aging Products and Therapies Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Corneal(Allergan) Anti-Aging Products and Therapies Product Portfolio
  24. 7.4.5 Corneal(Allergan) Recent Developments
  25. 7.5 Galdermal
  26. 7.5.1 Galdermal Company Information
  27. 7.5.2 Galdermal Business Overview
  28. 7.5.3 Galdermal Anti-Aging Products and Therapies Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Galdermal Anti-Aging Products and Therapies Product Portfolio
  30. 7.5.5 Galdermal Recent Developments
  31. 7.6 LG Life Science
  32. 7.6.1 LG Life Science Company Information
  33. 7.6.2 LG Life Science Business Overview
  34. 7.6.3 LG Life Science Anti-Aging Products and Therapies Revenue and Gross Margin (2021-2026)
  35. 7.6.4 LG Life Science Anti-Aging Products and Therapies Product Portfolio
  36. 7.6.5 LG Life Science Recent Developments
  37. 7.7 Bohus BioTech
  38. 7.7.1 Bohus BioTech Company Information
  39. 7.7.2 Bohus BioTech Business Overview
  40. 7.7.3 Bohus BioTech Anti-Aging Products and Therapies Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Bohus BioTech Anti-Aging Products and Therapies Product Portfolio
  42. 7.7.5 Bohus BioTech Recent Developments
  43. 7.8 IMEIK
  44. 7.8.1 IMEIK Company Information
  45. 7.8.2 IMEIK Business Overview
  46. 7.8.3 IMEIK Anti-Aging Products and Therapies Revenue and Gross Margin (2021-2026)
  47. 7.8.4 IMEIK Anti-Aging Products and Therapies Product Portfolio
  48. 7.8.5 IMEIK Recent Developments
  49. 7.9 Merck
  50. 7.9.1 Merck Company Information
  51. 7.9.2 Merck Business Overview
  52. 7.9.3 Merck Anti-Aging Products and Therapies Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Merck Anti-Aging Products and Therapies Product Portfolio
  54. 7.9.5 Merck Recent Developments
  55. 7.10 Gaoxin
  56. 7.10.1 Gaoxin Company Information
  57. 7.10.2 Gaoxin Business Overview
  58. 7.10.3 Gaoxin Anti-Aging Products and Therapies Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Gaoxin Anti-Aging Products and Therapies Product Portfolio
  60. 7.10.5 Gaoxin Recent Developments
8 North America
  1. 8.1 North America Anti-Aging Products and Therapies Revenue (2021-2032)
  2. 8.2 North America Anti-Aging Products and Therapies Revenue by Type (2021-2032)
  3. 8.2.1 North America Anti-Aging Products and Therapies Revenue by Type (2021-2026)
  4. 8.2.2 North America Anti-Aging Products and Therapies Revenue by Type (2027-2032)
  5. 8.3 North America Anti-Aging Products and Therapies Revenue Share by Type (2021-2032)
  6. 8.4 North America Anti-Aging Products and Therapies Revenue by Application (2021-2032)
  7. 8.4.1 North America Anti-Aging Products and Therapies Revenue by Application (2021-2026)
  8. 8.4.2 North America Anti-Aging Products and Therapies Revenue by Application (2027-2032)
  9. 8.5 North America Anti-Aging Products and Therapies Revenue Share by Application (2021-2032)
  10. 8.6 North America Anti-Aging Products and Therapies Revenue by Country
  11. 8.6.1 North America Anti-Aging Products and Therapies Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Anti-Aging Products and Therapies Revenue by Country (2021-2026)
  13. 8.6.3 North America Anti-Aging Products and Therapies Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Anti-Aging Products and Therapies Revenue (2021-2032)
  2. 9.2 Europe Anti-Aging Products and Therapies Revenue by Type (2021-2032)
  3. 9.2.1 Europe Anti-Aging Products and Therapies Revenue by Type (2021-2026)
  4. 9.2.2 Europe Anti-Aging Products and Therapies Revenue by Type (2027-2032)
  5. 9.3 Europe Anti-Aging Products and Therapies Revenue Share by Type (2021-2032)
  6. 9.4 Europe Anti-Aging Products and Therapies Revenue by Application (2021-2032)
  7. 9.4.1 Europe Anti-Aging Products and Therapies Revenue by Application (2021-2026)
  8. 9.4.2 Europe Anti-Aging Products and Therapies Revenue by Application (2027-2032)
  9. 9.5 Europe Anti-Aging Products and Therapies Revenue Share by Application (2021-2032)
  10. 9.6 Europe Anti-Aging Products and Therapies Revenue by Country
  11. 9.6.1 Europe Anti-Aging Products and Therapies Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Anti-Aging Products and Therapies Revenue by Country (2021-2026)
  13. 9.6.3 Europe Anti-Aging Products and Therapies Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Anti-Aging Products and Therapies Revenue (2021-2032)
  2. 10.2 China Anti-Aging Products and Therapies Revenue by Type (2021-2032)
  3. 10.2.1 China Anti-Aging Products and Therapies Revenue by Type (2021-2026)
  4. 10.2.2 China Anti-Aging Products and Therapies Revenue by Type (2027-2032)
  5. 10.3 China Anti-Aging Products and Therapies Revenue Share by Type (2021-2032)
  6. 10.4 China Anti-Aging Products and Therapies Revenue by Application (2021-2032)
  7. 10.4.1 China Anti-Aging Products and Therapies Revenue by Application (2021-2026)
  8. 10.4.2 China Anti-Aging Products and Therapies Revenue by Application (2027-2032)
  9. 10.5 China Anti-Aging Products and Therapies Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti-Aging Products and Therapies Revenue (2021-2032)
  2. 11.2 Asia Anti-Aging Products and Therapies Revenue by Type (2021-2032)
  3. 11.2.1 Asia Anti-Aging Products and Therapies Revenue by Type (2021-2026)
  4. 11.2.2 Asia Anti-Aging Products and Therapies Revenue by Type (2027-2032)
  5. 11.3 Asia Anti-Aging Products and Therapies Revenue Share by Type (2021-2032)
  6. 11.4 Asia Anti-Aging Products and Therapies Revenue by Application (2021-2032)
  7. 11.4.1 Asia Anti-Aging Products and Therapies Revenue by Application (2021-2026)
  8. 11.4.2 Asia Anti-Aging Products and Therapies Revenue by Application (2027-2032)
  9. 11.5 Asia Anti-Aging Products and Therapies Revenue Share by Application (2021-2032)
  10. 11.6 Asia Anti-Aging Products and Therapies Revenue by Country
  11. 11.6.1 Asia Anti-Aging Products and Therapies Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Anti-Aging Products and Therapies Revenue by Country (2021-2026)
  13. 11.6.3 Asia Anti-Aging Products and Therapies Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti-Aging Products and Therapies Revenue (2021-2032)
  2. 12.2 SAMEA Anti-Aging Products and Therapies Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Anti-Aging Products and Therapies Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Anti-Aging Products and Therapies Revenue by Type (2027-2032)
  5. 12.3 SAMEA Anti-Aging Products and Therapies Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Anti-Aging Products and Therapies Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Anti-Aging Products and Therapies Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Anti-Aging Products and Therapies Revenue by Application (2027-2032)
  9. 12.5 SAMEA Anti-Aging Products and Therapies Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Anti-Aging Products and Therapies Revenue by Country
  11. 12.6.1 SAMEA Anti-Aging Products and Therapies Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Anti-Aging Products and Therapies Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Anti-Aging Products and Therapies Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst